Related Experiment Videos
Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis
A B Chang1, C A Byrnes, M L Everard
1Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT; Queensland Children's Respiratory Centre and Queensland Children's Medical Research Institute, Royal Children's Hospital, Brisbane, Australia. annechang@ausdoctors.net
Paediatric Respiratory Reviews
|April 5, 2011
Summary
Diagnosing childhood bronchiectasis using radiology has limitations. Early and intensive treatment can limit airway damage progression, even in those predisposed to the condition.
Area of Science:
- Pediatric Pulmonology
- Radiology
- Medical Diagnostics
Background:
- Current radiological diagnostic criteria for childhood bronchiectasis, primarily derived from adult data, present significant limitations.
- These limitations include the need for multiple high-resolution computed tomography (HRCT) scans, radiation exposure, potential for false negatives/positives, and a lack of normative pediatric broncho-arterial ratio data.
- Childhood airway diseases exist on a spectrum, from protracted bacterial bronchitis to irreversible dilatation with cystic formation.
Purpose of the Study:
- To highlight the limitations of current radiological diagnostic methods for childhood bronchiectasis.
- To propose a conceptual framework for understanding childhood bronchiectasis as a spectrum of airway inflammation and damage.
- To emphasize the potential for intensive treatment to mitigate disease progression.
Main Methods:
- Review of existing literature on childhood bronchiectasis diagnosis and treatment.
- Analysis of limitations associated with current radiological assessment, including HRCT and multi-detector CT scans.
- Conceptualization of a disease spectrum model based on bacterial involvement and airway damage.
Main Results:
- Radiological diagnosis of childhood bronchiectasis faces challenges including radiation exposure, reliance on adult criteria, and diagnostic inaccuracies.
- A spectrum of airway disease exists, influenced by bacterial presence and inflammation, leading to varying degrees of airway damage.
- Intensive treatment strategies show promise in limiting disease progression, even in high-risk pediatric populations.
Conclusions:
- Current radiological diagnostic approaches for pediatric bronchiectasis are suboptimal.
- A spectrum-based understanding of airway disease progression is crucial.
- Timely and intensive therapeutic interventions are vital for managing childhood bronchiectasis and preventing irreversible lung damage.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation